deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT00932971

HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis (HIDIT-II)

A Multicenter Randomised Study Comparing the Efficacy of PegIFN-alfa2a Plus Placebo vs. PegIFN-alfa2a Plus Tenofovir for the Treatment of Chronic Delta Hepatitis-The Hep-Net International Delta Hepatitis Interventional Trial II (HIDIT-II)

Sponsor: Gilead Sciences

Conditions Hepatitis D
Interventions PEG-IFN alfa-2a, Tenofovir PEG-IFN alfa-2a, placebo
Updated 8 times since 2017 Last updated: Jan 26, 2018 Started: Jun 30, 2009 Primary completion: Aug 31, 2017 Completion: Aug 2, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Hepatitis D, this trial is completed. The trial is conducted by Gilead Sciences and has accumulated 8 data snapshots since 2009. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshotActive Not Recruiting~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotCompleted~Jun 2018 – ~Jul 2019 · 13 months · monthly snapshotCompleted~Jul 2019 – ~Jan 2021 · 18 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jul 2019 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 3 earlier versions

  1. Jun 2018 — Jul 2019 [monthly]

    Completed PHASE2

  2. Sep 2017 — Jun 2018 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  3. Jan 2017 — Sep 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Gilead Sciences
  • Hannover Medical School
  • HepNet Study House, German Liverfoundation
  • Hoffmann-La Roche
Data source: HepNet Study House, German Liverfoundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations